Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
Ways for vaccines improvment are described. WHO criteria and domestic requirements for influenza vaccines quality are presented. The multicenter, double-blind, randomized trial in parallel groups of the first Russian quadrivalent vaccine is described in details. Multicenter study for assessment of v...
Saved in:
| Main Author: | D. A. Lioznov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2018-09-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01) -
The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases
by: Wanqin Tang, et al.
Published: (2025-08-01) -
Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases
by: Frontiers Production Office
Published: (2025-08-01) -
Navigating the crossroads of health and wealth: socioeconomic inequality in flu vaccination uptake among the elderly in Iran
by: Satar Rezaei, et al.
Published: (2025-07-01) -
Use of complementary medicine and uptake of COVID-19 vaccination among US adults
by: Holger Cramer, et al.
Published: (2025-06-01)